Interactions Among Hippocampal Interneuron Circuits

海马中间神经元回路之间的相互作用

• 批准号: 7800251
• 负责人: BRADLEY E ALGER
• 金额: $ 27.58万
• 依托单位: UNIVERSITY OF MARYLAND BALTIMORE
• 依托单位国家: 美国
• 财政年份: 2006
• 资助国家: 美国
• 起止时间: 2006-04-01 至 2011-03-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7800251
• 关键词: Affect; Behavior; Behavioral; Brain; Brain Diseases; CNR1 gene; Cannabinoids; Cholecystokinin; Complex; Drug Delivery Systems; Drug abuse; Endocannabinoids; Epilepsy; Hippocampus (Brain); In Vitro; Interneurons; Link; Mediating; Molecular; Neurons; Neuropeptides; Opioid; Opioid Receptor; Optics; Output; Parvalbumins; Predisposition; Property; Pyramidal Cells; Role; Schizophrenia; Slice; Structure; System; Techniques; Testing; Tetragastrin; Ursidae Family; Work; drug of abuse; endogenous cannabinoid system; endogenous opioids; mu opioid receptors; neurophysiology; receptor; response

DESCRIPTION (provided by applicant): The endogenous opioid and cannabinoid systems are powerful neurophysiological modulators of excitability in the brain, and have been linked to numerous behaviors. They are also substrates for drugs of abuse. Yet despite their unique molecular and pharmacological identities, the systems often appear to be intertwined, and drugs targeted to one system can modify responses mediated by the other system. The cellular interface between opioids and cannabinoids is not generally understood: it probably varies depending on the brain structures and behaviors involved. The mammalian hippocampus has intricate endogenous opioid and cannabinoid systems which have been studied individually. However, there is virtually no information about the ways in which they overlap or how they might interact. A potentially crucial link may be provided by the neuropeptide, cholecystokinin (CCK), which potently controls actions mediated by a major opioid receptor, the f-receptor (MOR), at both cellular and behavioral levels. The endogenous cannabinoid system in hippocampus is targeted mainly to the particular set of GABAergic interneurons that also contain CCK. In hippocampus, the brain cannabinoid receptor, CB1, is almost exclusively expressed by CCK-containing interneurons. The f-opioid receptor is localized on the neurochemically-distinct, parvalbumin-containing interneurons, that express neither CCK nor CB1. The precise and complex convergence of these three systems onto interneurons that target pyramidal cells, which are the major hippocampal output neurons, cannot be a chance occurrence. The objective of this proposal is to test the Working Hypothesis that the endogenous opioid, cannabinoid and CCK systems mutually interact via hippocampal interneurons, and thereby jointly regulate the excitability and susceptibility to short- and long-term plasticity of the pyramidal cells. The prominent roles of these systems in drug abuse and major brain disorders such as epilepsy and schizophrenia underscore the significance of the inherent unresolved questions. We will use a variety of experimental approaches in in vitro brain slices, including electrophysiological, immunocytochemical, and optical techniques, to test the major hypothesis of this project. The Specific Aims are to test the following hypotheses: 1. The interneurons that are sensitive to opioids and cannabinoids can be functionally classified by their pharmacological properties. 2. CCK affects both f-opioid and endocannabinoid-sensitive interneurons. 3. Short-term inhibitory response plasticities mediated via MORs and CB1 interact with each other and with CCK. 4. Long-term inhibitory response plasticities mediated via MORs and CB1 interact with each other and with CCK.

描述（由申请人提供）：内源性阿片类药物和大麻素系统是大脑中兴奋性的强大神经生理调节剂，并且与许多行为有关。他们也是滥用药物的基板。然而，尽管它们具有独特的分子和药理身份，但这些系统似乎通常是交织在一起的，针对一个系统的药物可以修改另一个系统介导的反应。通常不了解阿片类药物和大麻素之间的细胞界面：它可能取决于所涉及的大脑结构和行为。哺乳动物海马具有复杂的内源性阿片类药物和大麻素系统，这些系统已被单独研究。但是，几乎没有关于它们重叠或如何相互作用的方式的信息。神经肽（CCK）可以提供潜在的至关重要的联系，该神经肽（CCK）在细胞和行为水平上都可以有力控制由主要的阿片受体（MOR）介导的作用。海马中的内源性大麻素系统主要针对一组也包含CCK的GABA能中间神经元。在海马中，脑大麻素受体CB1几乎完全由含CCK的中间神经元表达。 F-阿片类受体位于神经化的含白蛋白的神经元上，该神经元既不表达CCK也不表达CCK也不表达CB1。这三个系统在靶向锥体细胞的中间神经元上的精确而复杂的收敛性（这是主要的海马输出神经元）并不是偶然的发生。该提案的目的是检验可行的假设，即内源性阿片类药物，大麻素和CCK系统通过海马中间神经元相互相互作用，从而共同调节了对金​​字塔细胞短期可塑性的兴奋性和易感性。这些系统在药物滥用和主要脑部疾病中的重要作用，例如癫痫和精神分裂症，强调了固有的未解决问题的重要性。我们将在体外脑切片中使用各种实验方法，包括电生理，免疫细胞化学和光学技术，以测试该项目的主要假设。具体目的是检验以下假设：1。对阿片类药物和大麻素敏感的中间神经元可以通过其药理特性在功能上分类。 2。CCK会影响F-阿片类药物和内源性大麻素敏感的中间神经元。 3。通过MOR和CB1介导的短期抑制反应可塑性彼此相互作用，并与CCK相互作用。 4。通过MOR和CB1介导的长期抑制反应可塑性相互相互作用，并与CCK相互作用。